Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted...

By Victor Crawford, Chief Executive Officer, Pharmaceutical Segment

By Tiffany Olson, president of Nuclear & Precision Health Solutions at Cardinal Health. From HealthCare Business News magazine: Precision medicine is an area of healthcare that targets treatment...

Four years after the approval of the first CAR-T cell therapies, oncologists are referring more patients for treatment and becoming more comfortable with the cost. However, payer approvals and...

The month of June marks the celebration of LGBTQ+ (lesbian, gay, bisexual, transgender, queer and others) Pride in communities across the country. Pride Month commemorates the 1969 Stonewall...

Like many pharmacists across the country, Jana Bennett, RPh, head pharmacist at a Medicine Shoppe pharmacy in Sherman, Texas, had to react quickly when she received only five days’ notice of the...

By Suzanne Foster, President, Cardinal Health at-Home Solutions The shift to virtual care is transforming healthcare. Thanks to ever-improving technologies and digital tools, virtual care was...

Patients with end-stage kidney disease are often in fragile health, and because of their weakened immune systems, they are at high risk of becoming severely ill from COVID-19. Yet, until recently,...